https://www.selleckchem.com/CDK.html
Acceptance of V95% of CTV, V90% of CTV, and V80% of rectum was obtained in 123 (94%), 125 (95%) and 117 sessions (89%), respectively. Acceptance of the mean dose of V95% of CTV, V90% of CTV, and V80% of rectum for each patient was obtained in 10 (91%), 10 (91%), and 11 patients (100%), respectively. We demonstrated acceptable interfractional robustness based on the dose distribution in scanning CIRT for prostate cancer. We demonstrated acceptable interfractional robustness based on the dose distribution in scanning CIRT for prostate cancer.Figurate
Curtir
Comentario
Compartilhar
